NEW YORK, March 26, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company focused on developing first-in-class therapies for allergic and inflammatory diseases ...

Hoth Therapeutics (HOTH) announced breakthrough preclinical findings demonstrating the efficacy of HT-KIT, a novel targeted therapy for gastrointestinal stromal tumors. The results highlight HT ...

NEW YORK, March 31, 2025 /PRNewswire/ --Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused clinical-stage biopharmaceutical company, today announced that it has received an official Filing ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

[All Parts Combined] has the solution for you, with a Kinect-based robotic sentry turret to keep them at bay. The system consists of a Microsoft Kinect V2 connected to a PC, which runs an app to ...

At close: 27 March at 4:00:02 pm GMT-4 ...

(RTTNews) - Hoth Therapeutics, Inc. (HOTH) Wednesday reported positive results from the preclinical study of its lead drug candidate HT-ALZ for the treatment of Alzheimer's disease. HT-ALZ has ...